Ariën KK - Search Results

1

Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission.

Ariën KK, Venkatraj M, Michiels J, Joossens J, Vereecken K, Van der Veken P, Abdellati S, Cuylaerts V, Crucitti T, Heyndrickx L, Heeres J, Augustyns K, Lewi PJ, Vanham G. Ariën KK, et al. J Antimicrob Chemother. 2013 Sep;68(9):2038-47. doi: 10.1093/jac/dkt166. Epub 2013 May 3. J Antimicrob Chemother. 2013. PMID: 23645585

2

Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time.

Ariën KK, Troyer RM, Gali Y, Colebunders RL, Arts EJ, Vanham G. Ariën KK, et al. AIDS. 2005 Oct 14;19(15):1555-64. doi: 10.1097/01.aids.0000185989.16477.91. AIDS. 2005. PMID: 16184024

3

Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones.

Ariën KK, Gali Y, El-Abdellati A, Heyndrickx L, Janssens W, Vanham G. Ariën KK, et al. Virology. 2006 Mar 30;347(1):65-74. doi: 10.1016/j.virol.2005.11.045. Epub 2005 Dec 28. Virology. 2006. PMID: 16386774 Free article.

4

The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness.

Njai HF, Gali Y, Vanham G, Clybergh C, Jennes W, Vidal N, Butel C, Mpoudi-Ngolle E, Peeters M, Ariën KK. Njai HF, et al. Among authors: arien kk. Retrovirology. 2006 Jul 3;3:40. doi: 10.1186/1742-4690-3-40. Retrovirology. 2006. PMID: 16817969 Free PMC article.

5

Is HIV-1 evolving to a less virulent form in humans?

Ariën KK, Vanham G, Arts EJ. Ariën KK, et al. Nat Rev Microbiol. 2007 Feb;5(2):141-51. doi: 10.1038/nrmicro1594. Epub 2007 Jan 4. Nat Rev Microbiol. 2007. PMID: 17203103 Free PMC article. Review.

6

Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort.

Gali Y, Berkhout B, Vanham G, Bakker M, Back NK, Ariën KK. Gali Y, et al. Among authors: arien kk. Virology. 2007 Jul 20;364(1):140-6. doi: 10.1016/j.virol.2007.02.021. Epub 2007 Mar 28. Virology. 2007. PMID: 17395236 Free article.

7

Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity.

Gali Y, Ariën KK, Praet M, Van den Bergh R, Temmerman M, Delezay O, Vanham G. Gali Y, et al. Among authors: arien kk. J Virol Methods. 2010 May;165(2):186-97. doi: 10.1016/j.jviromet.2010.01.018. Epub 2010 Feb 4. J Virol Methods. 2010. PMID: 20138087

8

In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides.

Gali Y, Delezay O, Brouwers J, Addad N, Augustijns P, Bourlet T, Hamzeh-Cognasse H, Ariën KK, Pozzetto B, Vanham G. Gali Y, et al. Among authors: arien kk. Antimicrob Agents Chemother. 2010 Dec;54(12):5105-14. doi: 10.1128/AAC.00456-10. Epub 2010 Oct 4. Antimicrob Agents Chemother. 2010. PMID: 20921308 Free PMC article.

9

First real success for anti-HIV gel: a new start for HIV microbicides?

Ariën KK, Vanham G. Ariën KK, et al. Future Microbiol. 2010 Nov;5(11):1621-3. doi: 10.2217/fmb.10.129. Future Microbiol. 2010. PMID: 21133683 No abstract available.

10

The "gatekeeper" hypothesis challenged in a human cervico-vaginal tissue model for HIV-1 transmission.

Ariën KK, Gali Y, Vanham G. Ariën KK, et al. Mucosal Immunol. 2011 Jan;4(1):121-2; author reply 122-3. doi: 10.1038/mi.2010.45. Epub 2010 Dec 8. Mucosal Immunol. 2011. PMID: 21150895 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters